View in EDS

An evaluation of the utility of LVdP/dt40, QA interval, LVdP/dtmin and Tau as indicators of drug-induced changes in contractility and lusitropy in dogs.

Saved in:

Bibliographic Details
Title:	An evaluation of the utility of LVdP/dt40, QA interval, LVdP/dtmin and Tau as indicators of drug-induced changes in contractility and lusitropy in dogs.
Authors:	Pugsley MK; Purdue Pharma, LP, Cranbury, NJ, United States., Guth B; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Chiang AY; Eli Lilly and Company, Indianapolis, IN, United States., Doyle JM; Data Sciences International, St. Paul, MN, United States., Engwall M; Amgen, Thousand Oaks, CA, United States., Guillon JM; Sanofi, Vitry sur Seine, France., Hoffmann PK; Novartis, East Hanover, NJ, United States., Koerner JE; FDA, Washington, DC, United States., Mittelstadt SW; AbbVie, Abbott Park, IL, United States., Pierson JB; HESI, Washington, DC, United States., Rossman EI; GlaxoSmithKline, King of Prussia, PA, United States., Sarazan DR; Independent, Rhinelander, WI, United States., Parish ST; HESI, Washington, DC, United States. Electronic address: sparish@hesiglobal.org.
Source:	Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2017 May - Jun; Vol. 85, pp. 1-21. Date of Electronic Publication: 2017 Jan 05.
Publication Type:	Journal Article
Journal Info:	Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1873-488X
DOI:	10.1016/j.vascn.2017.01.002